NKTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Nkarta (NKTX) Earnings Date & Reports

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NKTX is expected to report earnings to rise 28.49% to -44 cents per share on May 08

Q1'25

Est.

$-0.45

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.13

Q1'24

Missed

by $0.03

The last earnings report on March 26 showed earnings per share of -34 cents, beating the estimate of -39 cents. With 792.51K shares outstanding, the current market capitalization sits at 141.92M.

View a ticker or compare two or three

Compare

NKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NKTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1150 Veterans Boulevard

Phone

+1 905 407-1049

Employees

150

Web

https://www.nkartatx.com